The marked upregulation of IL6R and TNF receptors (TNFRSF1A, TNFRSF1B) in cancer tissue compared to controls supports the notion that these cytokines and their signaling pathways are central to the development and aggressiveness of endometrial cancer. This evidence concerns the gene TNFRSF1B and endometrial cancer.